Full Committee Hearing: “Developments in the Prescription Drug Market: Oversight”

Hearing

Date: Thursday, February 4, 2016 Time: 10:00 AM Location: 2154 Rayburn HOB

There was no video broadcast for this event.

Agenda

Ranking Member Elijah Cummings' Opening Satement 

Witnesses

Invited Witnesses

Dr. Janet Woodcock
Director, Center for Drug Evaluation and Research    
U.S. Food and Drug Administration    

Mr. Howard B. Schiller
Interim Chief Executive Officer    
Valeant Pharmaceuticals International, Inc.    

Mr. Martin Shkreli
Former Chief Executive Officer    
Turing Pharmaceuticals LLC    

Ms. Nancy Retzlaff
Chief Commercial Officer    
Turing Pharmaceuticals LLC    

Mr. Mark Merritt
President and Chief Executive Officer    
Pharmaceutical Care Management Association